Navigation Links
Shark Cartilage Not Beneficial in Advanced Lung Cancer
Date:5/26/2010

Study found no difference in survival when compared to chemoradiotherapy alone

WEDNESDAY, May 26 (HealthDay News) -- A drug derived from shark cartilage failed to improve survival in patients with advanced lung cancer, researchers report.

The disappointing results, which came in the final stage of testing, showed that the drug didn't help extend the life spans of patients with inoperable stage III non-small cell lung cancer.

Scientists have been testing drugs derived from shark cartilage because it appears to prevent blood vessels from growing around tumors. The hope is that the drugs will prevent cancer cells from being fed by blood, which allows them to grow.

Researchers led by Dr. Charles Lu, of the University of Texas M.D. Anderson Cancer Center, tested the specific drug in question, known as AE-941, on patients in the United States and Canada.

In the study, published online May 26 in the Journal of the National Cancer Institute, a total of 379 patients with inoperable non-small cell lung cancer were treated with chemoradiotherapy and either AE-941 or an inactive placebo.

There was no significant difference in outcome between the two groups in terms of overall survival, or in length of time before the disease progressed, the researchers found.

The study authors noted that the study's impetus was "the widespread use of poorly regulated complementary and alternative medicine products, such as shark cartilage-derived agents, among patients with advanced cancer, a population likely to be vulnerable to unsubstantiated marketing claims."

More information

For more on lung cancer, try the U.S. National Library of Medicine.



-- Randy Dotinga



SOURCE: Oxford Journals, news release, May 26, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Shark Attack Study Announced: Politics of Bite Incidents Under Review
2. Nanofiber Gel May Spur Growth of New Knee Cartilage
3. Cartilage repair can improve life, ease burden on health services
4. NIH study confirms location of stem cells near cartilage-rich regions in bones
5. Major New Study Finds Soyfoods Safe and Beneficial for Women With Breast Cancer
6. Soy Beneficial for Breast Cancer Survivors: Study
7. Medication appears well-tolerated, beneficial in Huntingtons disease patients
8. Chocolate Industry Leaders Sign Agreement, Align on Path Towards Increasing Consumer Availability & Consistency of Beneficial Cocoa Flavanols
9. Screens, Vaccine for HPV Less Beneficial in Older Women
10. Beneficial Microorganisms Rescue Chilean Earthquake Victims
11. Probiotics Beneficial for Tiniest Preemies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... DKT International, ... the developing world, is pleased to release their 2015 global impact data. In ... pregnancies, almost 14,000 maternal deaths and 3.8 million unsafe abortions across 21 countries ...
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel Actuaries, delivering ... and Prescription Drug survey , an employee benefits survey measuring how ... in December 2015, indicates that employers are turning to consumer directed health care ...
(Date:5/25/2016)... ... May 25, 2016 , ... "FCPX LUT Intense allows ... your footage," said Christina Austin - CEO of Pixel Film Studios. , With ... and easily add stylish color grades to their footage. A LUT is a Lookup ...
(Date:5/25/2016)... ... May 25, 2016 , ... HealthPostures ... will join America's leading engineers at the American Society of Safety Engineers Conference ... Congress Center. , Engineers, speakers and exhibitors from more than 40 countries ...
(Date:5/24/2016)... ... May 24, 2016 , ... BTC Media, ... blockchain event, Distributed: Health, to be held in Nashville, Tennessee on September 7, ... A 24-hour Hackathon preceding the event will host teams from around the world, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... LONDON , May 24, 2016   ... primary endpoints demonstrating non-inferiority in overall bowel cleansing and superiority ... c leansing of ... http://photos.prnewswire.com/prnh/20130829/633895-a ) , Norgine B.V. today announced ... (1 litre PEG and ascorbate bowel preparation) versus standard 2 litre ...
(Date:5/24/2016)... LAWRENCEVILLE, N.J. , May 24, 2016 /PRNewswire/ ... an oncology drug development company, today provided an ... Ib dose escalating clinical trial combining GEN-1, the ... for the treatment of newly-diagnosed patients with advanced ... by interval debulking surgery.  GEN-1 is an IL-12 ...
Breaking Medicine Technology: